Objective-To evaluate dynamic contrast enhanced computed tomography for detecting and localising pancreatic necrosis in acute pancreatitis.
Introduction
Fatal acute pancreatitis is often associated with septic complications of pancreatic necrosis,' 2 which we define as a collection of solid necrotic tissue3 rather than pus (pancreatic abscess) or pancreatic juice (pseudocyst). Collections of pus and pancreatic juice are associated with lower morbidity and mortality.45 Survival of patients with pancreatic necrosis often depends on surgical debridement of necrotic tissue.246 Before surgery the presence and extent of pancreatic necrosis must be identified. This cannot be achieved by clinical assessment,7 laboratory criteria,79 or ultrasonography,"'0 and even at laparotomy surgeons cannot differentiate accurately between necrotic and viable tissue" or between necrotic pancreas and necrotic peripancreatic fat. 2 Computed tomography shows characteristic changes in pancreatic and peripancreatic tissues during acute pancreatitis,'3" 14 and although a correlation with outcome has been shown,'3 151 6 the extent to which the results of computed tomography are prognostic is disputed. 'I-" The pancreas is richly vascularised and its density in computed tomograms is considerably increased, or (fig 3 (bottom) ).
Of the remaining 40 patients, 36 had normal enhancement throughout and four had equivocal pancreatic enhancement initially which had returned to normal on rescanning 48 hours later. All 40 patients survived without requiring debridement of pancreatic necrosis, but collections of fluid were drained in 12 (from a pseudocyst in nine and a pancreatic abscess in three; by percutaneous puncture in five and by operation in seven). All Pancreatic enhancement after intravenous administration of con'trast medium may be influenced by the nature and volume of the contrast medium, injection speed, cardiac output, blood volume, splanchnic perfusion, and elimination of the medium from the circulation. Capillary blood flow was the principal determinant of enhancement in pigs with acute pancreatitis,24 and microangiography of human pancreatectomy specimens confirmed that microcirculatory damage in pancreatic necrosis corresponds with abnormal enhancement. 25 A clearer understanding of the pathological evolution of pancreatic necrosis is now emerging,' 2 452 and the survival of patients treated in specialist units has improved,246 possibly because patients likely to require surgical debridement are more accurately identified.248 3 Pancreatic necrosis may be sterile or infected, l26 and whereas the patients with infected necrosis are typically the most severely ill,' sterile pancreatic necrosis can be lethal.''3 Computed tomography cannot differentiate between infected and sterile necrosis,' but percutaneous aspiration guided by computed tomography can do so reliably.26
Dynamic contrast enhanced computed tomography identified and localised pancreatic necrosis precisely and proved safe when patients were given a non-ionic intravenous contrast medium. Doubts about safety will probably persist, but we believe that dynamic computed tomography should be used when pancreatic necrosis is suspected even in severely ill patients because of the precise information it provides. It did not indicate when an operation was necessary, but when surgery was indicated clinically it provided information that facilitated a less invasive surgical procedure and ensured that all necrotic tissue was located and debrided adequately. Intervention -Secretory phase endometrial biopsy specimens were taken, with informed consent, as an outpatient procedure.
Main outcome measures -Immunohistochemistry with monoclonal antibody D9B1, was used to assess the production and secretion of an oligosaccharide epitope produced by endometrial gland cells between two and seven days after the luteinising hormone surge. A reflected light measuring system was used to assess the amount of epitope within the gland cells, and in the gland lumen.
Results-In the control group of women, mean reflected light measurements at the cell base and cell apex peaked at three and five days after the luteinising hormone surge respectively, and in the gland lumen the epitope accumulated rapidly from three days, reaching a peak at seven days. In the women with infertility the peaks of epitope at the cell base and cell apex were lower, broader, and delayed in onset, and the build up of epitope in the gland lumen was retarded. The synthesis and secretion of the epitope in the women with infertility was therefore significantly reduced and delayed, even in the presence of normal concentrations of circulating progesterone.
Conclusions-The results suggest that a primary dysfunction of the endometrium might be associated with hitherto unexplained infertility.
Substantial numbers of patients with unexplained infertility attend infertility clinics, with reported prevalences ranging from 6% to almost 60%.' The hormonal profiles of women with unexplained infertility have been much studied and are often normal, but in contrast, the endometrium has been comparatively unexplored as a factor in infertility. This has been justified by the widespread belief that endometrial morphology provides no more than a simple and faithful reflection of the ovarian cycle. The use of the endometrial biopsy specimen as an index of ovulation has been largely superseded by non-invasive, quantitative, sensitive, endocrine assays, and failure of the endometrium to respond fully to a normal ovarian stimulus has remained hypothetical.
The secretory differentiation of the endometrial epithelium has been characterised by raising monoclonal antibodies to hormonally regulated cell surface and secretory components." The monoclonal antibody D9B1 binds to a peptide associated sialooligosaccharide of the sulphated lactosaminoglycan family, 6 which is secreted by gland cells mainly between three and seven days after the luteinising hormone surge.4 Study of the defective luteal phase has shown that there is a strong correlation between infertility and reduced production of the D9B 1 epitope7; this deficiency may occur against a background of normal secretory differentiation as assessed by conventional histology. On the basis of these and
